CFTR modulators and biologics have had a significant impact on the treatment of cystic fibrosis and severe asthma in recent years. Despite all the benefits that these active substances bring, some patients can also experience significant side effects. Some extrapulmonary consequences still receive too little attention in practice.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
How origin and place of residence promote CF-associated diabetes
- Patients with leg swelling
DVT and other common DDs with peripheral edema
- Pancreatic Cancer
Innovative early detection with a focus on liquid biopsy and AI
- Cervical Cancer
HPV prevention, screening innovation and sentinel lymph node biopsy
- Polypharmacy: use of eHealth tools in Switzerland
Survey study in primary care
- From symptom to diagnosis
Abdominal pain – Prostate abscess
- Asthma during pregnancy
Up to 40% suffer worsening of symptoms during pregnancy
- From symptom to diagnosis